| Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ... The Journal of clinical investigation 126 (3), 1052-1066, 2016 | 1051 | 2016 |
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma I Comino-Méndez, FJ Gracia-Aznárez, F Schiavi, I Landa, ... Nature genetics 43 (7), 663-667, 2011 | 583 | 2011 |
| Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease I Landa, I Ganly, TA Chan, N Mitsutake, M Matsuse, T Ibrahimpasic, ... The Journal of Clinical Endocrinology & Metabolism 98 (9), E1562-E1566, 2013 | 465 | 2013 |
| Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance RM Tuttle, JA Fagin, G Minkowitz, RJ Wong, B Roman, S Patel, B Untch, ... JAMA Otolaryngology–Head & Neck Surgery 143 (10), 1015-1020, 2017 | 445 | 2017 |
| Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes LJ Leandro‐García, S Leskelä, I Landa, C Montero‐Conde, ... Cytoskeleton 67 (4), 214-223, 2010 | 309 | 2010 |
| Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes I Ganly, V Makarov, S Deraje, YY Dong, E Reznik, V Seshan, ... Cancer cell 34 (2), 256-270. e5, 2018 | 240 | 2018 |
| Alternative transcription initiation leads to expression of a novel ALK isoform in cancer T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ... Nature 526 (7573), 453-457, 2015 | 237 | 2015 |
| Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas E López-Jiménez, G Gómez-López, LJ Leandro-García, I Muñoz, ... Molecular endocrinology 24 (12), 2382-2391, 2010 | 221 | 2010 |
| The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors I Landa, S Ruiz-Llorente, C Montero-Conde, L Inglada-Pérez, F Schiavi, ... PLoS genetics 5 (9), e1000637, 2009 | 196 | 2009 |
| Genetics of pheochromocytoma and paraganglioma in Spanish patients A Cascon, G Pita, N Burnichon, I Landa, E Lopez-Jiménez, ... The Journal of Clinical Endocrinology & Metabolism 94 (5), 1701-1705, 2009 | 165 | 2009 |
| Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases B Xu, T Fuchs, S Dogan, I Landa, N Katabi, JA Fagin, RM Tuttle, ... Thyroid 30 (10), 1505-1517, 2020 | 163 | 2020 |
| Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity S Leskelä, C Jara, LJ Leandro-Garcia, A Martinez, J Garcia-Donas, ... The pharmacogenomics journal 11 (2), 121-129, 2011 | 161 | 2011 |
| Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis C Rodríguez-Antona, J Pallares, C Montero-Conde, L Inglada-Pérez, ... Endocrine-Related Cancer 17 (1), 7-16, 2010 | 143 | 2010 |
| Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies I Landa, N Pozdeyev, C Korch, LA Marlow, RC Smallridge, JA Copland, ... Clinical Cancer Research 25 (10), 3141-3151, 2019 | 139 | 2019 |
| NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition MER Garcia-Rendueles, JC Ricarte-Filho, BR Untch, I Landa, JA Knauf, ... Cancer discovery 5 (11), 1178-1193, 2015 | 120 | 2015 |
| Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor … T Ibrahimpasic, B Xu, I Landa, S Dogan, S Middha, V Seshan, S Deraje, ... Clinical Cancer Research 23 (19), 5970-5980, 2017 | 107 | 2017 |
| Molecular characterisation of a common SDHB deletion in paraganglioma patients A Cascon, I Landa, E Lopez-Jimenez, A Díez-Hernández, M Buchta, ... Journal of medical genetics 45 (4), 233-238, 2008 | 91 | 2008 |
| Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells ML Gild, I Landa, M Ryder, RA Ghossein, JA Knauf, JA Fagin Endocrine-related cancer 20 (5), 659-667, 2013 | 73 | 2013 |
| Association studies in thyroid cancer susceptibility: are we on the right track? I Landa, M Robledo Journal of molecular endocrinology 47 (1), R43-58, 2011 | 73 | 2011 |
| EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC GP Krishnamoorthy, NR Davidson, SD Leach, Z Zhao, SW Lowe, G Lee, ... Cancer discovery 9 (2), 264-281, 2019 | 66 | 2019 |
James FaginPotvrđena adresa e-pošte na mskcc.org
